Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1000275 TORONTO, A6
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,705
+$12,317 QoQ
Shares Held
940
+754.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ENTA ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,705 940
2026-03-31 $1,388 110
2025-12-31 $13,876 880
2025-09-30 $14,136 1,181
2025-06-30 $20,426 2,702
2025-03-31 $13,263 2,403
2024-12-31 $15,070 2,621
2024-09-30 $22,334 2,156
2024-06-30 $25,667 1,979
2024-03-31 $9,497 544
2023-12-31 $62,961 6,691
2023-09-30 $41,507 3,716
2023-06-30 $57,031 2,665
2023-03-31 $63,894 1,580
2022-12-31 $156,165 3,357
2022-09-30 $36,567 705
2022-06-30 $27,273 577
2022-03-31 $118,727 1,668
2021-12-31 $273,394 3,656
2021-09-30 $137,479 2,420
2021-06-30 $62,009 1,409
2021-03-31 $4,733 96
2020-12-31 $211,510 5,024
2020-09-30 $255,269 5,576
2020-06-30 $234,380 4,668
2020-03-31 $254,732 4,953